Chris Chapman is delighted at GlucoRx’s achievement at the Surrey Super Growth Awards this year, ranking 6th out of 50,000 companies.
Lloyds Bank, asb law, and RSM compiled a shortlist of finalists based on profitable turnover growth over a four-year accounting period, using information filed at Companies House.
It was the first time GlucoRx attended the Super Growth Awards, being one of the top 50 companies invited to the Awards’ Breakfast.
The Surrey Super Growth Awards commented on GlucoRx in their top 50 published list. “It was great to be recognised for all the good work our Company has been doing, not only locally but across the whole of the UK”, said Chris Chapman.
GlucoRx would like to congratulate the 2019 winners ‘Stenball Group Limited’ with their winning growth of 267%, and look forward to qualifying for next year’s 2020 awards.
Dry skin is a common problem for those with diabetes – an estimated 80% of diabetics suffer from skin problems resulting from high blood sugar levels. This is due to the skin’s reduced ability to store moisture. The most prevalent cases of dry and chapped skin are those on the legs and feet. Symptoms can range from dryness to cracks, foot fungus, skin infection and ulceration. Without treatment, it can weaken the protective barrier of the skin and cause complications (i.e. progressing to foot amputation), so treatment is important.
Last month, GlucoRx joined forces with Allpresan and added the revolutionary foam creams to our extended range of products. GlucoRx Sales Director ‘Chris Chapman’ gave his input on why he feels it will be a productive move for the future – “It’s a great product we would like to bring into the GlucoRx family, and we would like all those with Diabetes to have healthy feet.”
May 2016 – FinePoint number 1 pen needle!
GlucoRx is proud to announce its FinePoint range is now the number one most prescribed Insulin pen needle in England (as per latest ePACT data). GlucoRx’s Sales Director Chris Chapman highlighted the company has done particularly well with FinePoint since it was launched only three years ago – “Our success is attributed to the fact we are uniquely positioned to offer this and other quality products to our NHS at a very competitive price; we want to make a difference!” (more…)